| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-043333 |
| cik | 1844392 |
| name | MARPAI, INC. |
| sic | 8090 |
| countryba | US |
| stprba | FL |
| cityba | TAMPA |
| zipba | 33602 |
| bas1 | 615 CHANNELSIDE DRIVE |
| bas2 | SUITE 207 |
| baph | 646-303-3483 |
| countryma | US |
| stprma | FL |
| cityma | TAMPA |
| zipma | 33602 |
| mas1 | 615 CHANNELSIDE DRIVE |
| mas2 | SUITE 207 |
| countryinc | US |
| stprinc | DE |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250514 |
| accepted | 2025-05-14 16:21:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0240771-10q_marpaiinc_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-043333 | 20241231 | Accounts And Other Receivables Net Current | 500000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Accounts And Other Receivables Net Current | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20241231 | Accrued Liabilities Current | 2585000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-043333 | 20250331 | Cash And Cash Equivalents At Carrying Value | 729000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Convertible Debt Current | 3037000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Convertible Debt Noncurrent | 8069000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Costs And Expenses | 7668000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Facilities Expense | 474000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -4346000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Liabilities And Stockholders Equity | 13718000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Net Cash Provided By Used In Financing Activities | 3705000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Net Cash Provided By Used In Operating Activities | -115000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Net Income Loss | -4346000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043333 | 20241231 | Operating Lease Liability Noncurrent | 793000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Other Assets Noncurrent | 15000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Other Liabilities Noncurrent | 15329000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Restricted Cash Current | 10780000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Share Based Compensation | 561000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Stockholders Equity | 66595000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043333 | 20250331 | Stockholders Equity | -101903000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-043333 | 20241231 | Unbilled Receivables Current | 569000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Accrued Fiduciary Obligations Current | 8227000.0000 | USD | 0 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20241231 | Additional Paid In Capital Common Stock | 71124000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 561000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043333 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-043333 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 574000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043333 | 20250331 | Assets | 13718000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Cash And Cash Equivalents At Carrying Value | 851000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 13492000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Contract With Customer Liability Current | 806000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Earnings Per Share Basic | -0.4600 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | -3000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Interest Paid Net | 403000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Liabilities And Stockholders Equity | 12878000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-043333 | 20241231 | Operating Lease Liability Current | 244000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Operating Lease Liability Noncurrent | 730000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 15000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Other Nonoperating Income | 120000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Prepaid Expense And Other Assets Current | 759000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Proceeds From Sale Of Future Cash Receipts On Accounts Receivable | USD | 1 | 0001213900-25-043333 | ||||
| 0001213900-25-043333 | 20241231 | Stockholders Equity | 71124000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043333 | 20250331 | Stockholders Equity | 71698000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043333 | 20250331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Shares New Issues | 2232100.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20240331 | Increase Decrease In Accounts Receivable | -800000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Accounts Receivable Net Current | 368000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Allowance For Doubtful Accounts Receivable Current | 1000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Assets Current | 12866000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9232000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 11509000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Common Stock Shares Outstanding | 14896686.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Earnings Per Share Diluted | -0.4600 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Increase Decrease In Accounts Payable | -373000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Increase Decrease In Accrued Fiduciary Obligations | 2063000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20250331 | Interest Expense Nonoperating | 819000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Interest Paid Net | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20240331 | Net Income Loss | -4346000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Net Income Loss | -3069000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043333 | 20250331 | Operating Lease Right Of Use Asset | 281000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Other Assets Noncurrent | 8000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Other Liabilities Noncurrent | 14891000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Payments To Seller For Acquisition | 196000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20240331 | Research And Development Expense | 7000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Restricted Cash Current | 8468000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Shares Outstanding | 14896686.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20241231 | Stockholders Equity | -27709000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250228 | Stock Issued During Period Shares Restricted Stock Award Gross | 82000.0000 | shares | 0 | us-gaap/2025 | Award Type= Restricted Stock Units R S U; | ||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-043333 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-043333 | 20250331 | Unbilled Receivables Current | 374000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 9405775.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Additional Paid In Capital Common Stock | 71698000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Accrued Liabilities Current | 1906000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Capitalized Computer Software Net | 441000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Common Stock Shares Authorized | 227791050.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Earnings Per Share Diluted | -0.2100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -3069000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20240331 | Increase Decrease In Other Operating Liabilities | 862000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 99000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Liabilities Current | 19794000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Net Cash Provided By Used In Financing Activities | 1892000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Net Cash Provided By Used In Operating Activities | -3585000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Operating Lease Liability Current | 248000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 62000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Other Liabilities Current | 18100000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= A X A; | ||
| 0001213900-25-043333 | 20250331 | Other Nonoperating Income | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20250331 | Payments Of Debt Issuance Costs | 162000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Proceeds From Convertible Debt | 3000000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Proceeds From Issuance Of Common Stock | 2727000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Restricted Cash Current | 12761000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Retained Earnings Accumulated Deficit | -98834000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Revenues | 7385000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20231231 | Stockholders Equity | -13438000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20231231 | Stockholders Equity | 63307000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 115000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20250131 | Stock Issued During Period Shares Restricted Stock Award Gross | 600000.0000 | shares | 0 | us-gaap/2025 | Title Of Individual= Board Of Directors Chairman; | ||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-043333 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 14770867.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Stockholders Equity | -30204000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Accounts Payable Current | 2736000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Accounts Receivable Net Current | 837000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-043333 | 20240331 | Amortization Of Financing Costs And Discounts | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 13612000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 2277000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20241231 | Common Stock Shares Issued | 14237176.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Earnings Per Share Basic | -0.2100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Increase Decrease In Operating Lease Liability | -59000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -151000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Liabilities | 40587000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Liabilities Current | 18982000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20250331 | Net Income Loss | -3069000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Other Liabilities Current | 2834000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Payments To Buyer Of Receivables | 57000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20250331 | Prepaid Expense And Other Assets Current | 615000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20240331 | Repayments Of Convertible Debt | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20250331 | Retained Earnings Accumulated Deficit | -101903000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Shares Outstanding | 14237176.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 659510.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-043333 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 9405775.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Assets Current | 11897000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Capitalized Computer Software Net | 334000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Cash And Cash Equivalents At Carrying Value | 764000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Common Stock Shares Authorized | 227791050.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Common Stock Shares Outstanding | 14237176.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Contract With Customer Liability Current | 625000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Convertible Debt Noncurrent | 5921000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 3484000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Costs And Expenses | 11450000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Deposits Assets Noncurrent | 229000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | General And Administrative Expense | 2283000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Increase Decrease In Accounts Receivable | -664000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Increase Decrease In Accrued Liabilities | -679000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Information Technology And Data Processing | 1124000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Interest Expense Nonoperating | 398000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Other Liabilities Current | 3005000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Payments Of Debt Issuance Costs | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20250331 | Payments To Buyer Of Receivables | USD | 1 | 0001213900-25-043333 | ||||
| 0001213900-25-043333 | 20250131 | Proceeds From Convertible Debt | 3000000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Proceeds From Sale Of Business Unit | 500000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20240331 | Proceeds From Sale Of Future Cash Receipts On Accounts Receivable | 1509000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20250331 | Repayments Of Convertible Debt | 750000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Research And Development Expense | 7000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Revenues | 5418000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Accrued Fiduciary Obligations Current | 6308000.0000 | USD | 0 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 561000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 574000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Allowance For Doubtful Accounts Receivable Current | 1000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 120000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001213900-25-043333 | 20250331 | Common Stock Shares Issued | 14896686.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Convertible Debt Current | 3106000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 4871000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Depreciation And Amortization | 951000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20240331 | Increase Decrease In Accrued Liabilities | 215000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Increase Decrease In Other Operating Liabilities | 181000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Net Cash Provided By Used In Investing Activities | 500000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-043333 | 20250331 | Operating Income Loss | -2250000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Payments To Seller For Acquisition | 474000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20240331 | Selling And Marketing Expense | 602000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Selling And Marketing Expense | 245000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Stockholders Equity | -14496000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Stockholders Equity | -81092000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043333 | 20241231 | Stockholders Equity | -98834000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value New Issues | 2727000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Stock Issued During Period Value New Issues | 2727000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043333 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 14770867.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Other Noncash Expense | 423000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Accounts Payable Current | 3109000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-043333 | 20250331 | Amortization Of Financing Costs And Discounts | -9000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Assets | 12878000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Deposits Assets Noncurrent | 229000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Depreciation And Amortization | 107000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Facilities Expense | 152000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20240331 | General And Administrative Expense | 3421000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Increase Decrease In Accounts Payable | -825000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Increase Decrease In Accrued Fiduciary Obligations | -1919000.0000 | USD | 1 | 0001213900-25-043333 | |||
| 0001213900-25-043333 | 20240331 | Increase Decrease In Operating Lease Liability | -126000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Information Technology And Data Processing | 1390000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Liabilities | 43922000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Operating Income Loss | -4065000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20241231 | Operating Lease Right Of Use Asset | 296000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20250331 | Other Noncash Expense | 463000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20240331 | Proceeds From Convertible Debt | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043333 | 20240331 | Proceeds From Sale Of Business Unit | USD | 1 | 0001213900-25-043333 | ||||
| 0001213900-25-043333 | 20250331 | Share Based Compensation | 574000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043333 | 20231231 | Shares Outstanding | 7960938.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20240331 | Shares Outstanding | 10308038.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20231231 | Stockholders Equity | -76746000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043333 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043333 | 20250331 | Stock Issued During Period Value Restricted Stock Award Gross | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Payments To Buyer Of Receivables | 0001213900-25-043333 | 1 | 0 | monetary | D | C | Payments To Buyer Of Receivables | Payments to buyer of receivables. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Convertible Debt Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Convertible Debt, Current | The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Other Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
| Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Capitalized Computer Software Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Capitalized Computer Software, Net | The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Proceeds From Sale Of Business Unit | 0001213900-25-043333 | 1 | 0 | monetary | D | D | Proceeds From Sale Of Business Unit | Represents the amount of proceeds from sale of business unit. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Convertible Debt Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Convertible Debt, Noncurrent | Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock. |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Selling And Marketing Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Contract With Customer Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
| Increase Decrease In Other Operating Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Operating Liabilities | Amount of increase (decrease) in operating liabilities classified as other. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Facilities Expense | 0001213900-25-043333 | 1 | 0 | monetary | D | D | Facilities Expense | Amount of facility expense. |
| Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Payments To Seller For Acquisition | 0001213900-25-043333 | 1 | 0 | monetary | D | C | Payments To Seller For Acquisition | Payments to seller for acquisition. |
| Accrued Fiduciary Obligations Current | 0001213900-25-043333 | 1 | 0 | monetary | I | C | Accrued Fiduciary Obligations Current | Amount of accrued fiduciary obligations, current. |
| Accounts And Other Receivables Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts and Other Receivables, Net, Current | Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Deposits Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Deposits Assets, Noncurrent | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer. |
| Depreciation And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Payments Of Debt Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments of Debt Issuance Costs | The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. |
| Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Gross | Aggregate value of stock related to Restricted Stock Awards issued during the period. |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Interest Expense Nonoperating | us-gaap/2025 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Proceeds From Convertible Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Convertible Debt | The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Revenues | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Amortization Of Financing Costs And Discounts | us-gaap/2025 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Increase Decrease In Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Information Technology And Data Processing | us-gaap/2025 | 0 | 0 | monetary | D | D | Information Technology and Data Processing | The amount of expenses incurred in the period for information technology and data processing products and services. |
| Interest Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activity | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Restricted Cash Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Other Noncash Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Other Noncash Expense | Amount of expense or loss included in net income that result in no cash flow, classified as other. |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. |
| Costs And Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
| Repayments Of Convertible Debt | us-gaap/2025 | 0 | 0 | monetary | D | C | Repayments of Convertible Debt | The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
| Proceeds From Sale Of Future Cash Receipts On Accounts Receivable | 0001213900-25-043333 | 1 | 0 | monetary | D | D | Proceeds From Sale Of Future Cash Receipts On Accounts Receivable | Proceeds from sale of future cash receipts on accounts receivable |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Allowance For Doubtful Accounts Receivable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Receivable, Allowance for Credit Loss, Current | Amount of allowance for credit loss on accounts receivable, classified as current. |
| Other Nonoperating Income | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Nonoperating Income | Amount of income related to nonoperating activities, classified as other. |
| Unbilled Receivables Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Unbilled Receivables, Current | Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer. |
| Increase Decrease In Accrued Fiduciary Obligations | 0001213900-25-043333 | 1 | 0 | monetary | D | C | Increase Decrease In Accrued Fiduciary Obligations | The increase (decrease) during the reporting period in accrued fiduciary obligations. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-043333 | 2 | 2 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001213900-25-043333 | 2 | 3 | BS | 0 | H | Restricted Cash Current | us-gaap/2025 | Restricted cash | 0 |
| 0001213900-25-043333 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable, net of allowance for credit losses of $1 and $1 as of March 31, 2025, and December 31, 2024, respectively | 0 |
| 0001213900-25-043333 | 2 | 5 | BS | 0 | H | Unbilled Receivables Current | us-gaap/2025 | Unbilled receivables | 0 |
| 0001213900-25-043333 | 2 | 6 | BS | 0 | H | Accounts And Other Receivables Net Current | us-gaap/2025 | Due from buyer for sale of business unit | 0 |
| 0001213900-25-043333 | 2 | 7 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-043333 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-043333 | 2 | 9 | BS | 0 | H | Capitalized Computer Software Net | us-gaap/2025 | Capitalized software, net | 0 |
| 0001213900-25-043333 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease right-of-use assets | 0 |
| 0001213900-25-043333 | 2 | 11 | BS | 0 | H | Deposits Assets Noncurrent | us-gaap/2025 | Security deposits | 0 |
| 0001213900-25-043333 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other long-term asset | 0 |
| 0001213900-25-043333 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001213900-25-043333 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-043333 | 2 | 16 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-043333 | 2 | 17 | BS | 0 | H | Accrued Fiduciary Obligations Current | 0001213900-25-043333 | Accrued fiduciary obligations | 0 |
| 0001213900-25-043333 | 2 | 18 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2025 | Deferred revenue | 0 |
| 0001213900-25-043333 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Current portion of operating lease liabilities | 0 |
| 0001213900-25-043333 | 2 | 20 | BS | 0 | H | Convertible Debt Current | us-gaap/2025 | Current portion of convertible debentures, net | 0 |
| 0001213900-25-043333 | 2 | 21 | BS | 0 | H | Other Liabilities Current | us-gaap/2025 | Other short-term liabilities | 0 |
| 0001213900-25-043333 | 2 | 22 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001213900-25-043333 | 2 | 23 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2025 | Other long-term liabilities | 0 |
| 0001213900-25-043333 | 2 | 24 | BS | 0 | H | Convertible Debt Noncurrent | us-gaap/2025 | Convertible debentures, net of current portion | 0 |
| 0001213900-25-043333 | 2 | 25 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Operating lease liabilities, net of current portion | 0 |
| 0001213900-25-043333 | 2 | 26 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001213900-25-043333 | 2 | 27 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | COMMITMENTS AND CONTINGENCIES (Note 16) | 0 |
| 0001213900-25-043333 | 2 | 29 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.0001 par value, 227,791,050 shares authorized; 14,896,686 shares and 14,237,176 shares issued and outstanding at March 31, 2025, and December 31, 2024, respectively | 0 |
| 0001213900-25-043333 | 2 | 30 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-043333 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-043333 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders deficit | 0 |
| 0001213900-25-043333 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders deficit | 0 |
| 0001213900-25-043333 | 3 | 1 | BS | 1 | H | Allowance For Doubtful Accounts Receivable Current | us-gaap/2025 | Accounts receivable, net of allowance for credit losses (in Dollars) | 0 |
| 0001213900-25-043333 | 3 | 2 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-043333 | 3 | 3 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-043333 | 3 | 4 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-043333 | 3 | 5 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding | 0 |
| 0001213900-25-043333 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2025 | Revenue | 0 |
| 0001213900-25-043333 | 4 | 3 | IS | 0 | H | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | us-gaap/2025 | Cost of revenue (exclusive of depreciation and amortization shown separately below) | 0 |
| 0001213900-25-043333 | 4 | 4 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001213900-25-043333 | 4 | 5 | IS | 0 | H | Information Technology And Data Processing | us-gaap/2025 | Information technology | 0 |
| 0001213900-25-043333 | 4 | 6 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2025 | Sales and marketing | 0 |
| 0001213900-25-043333 | 4 | 7 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
| 0001213900-25-043333 | 4 | 8 | IS | 0 | H | Depreciation And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
| 0001213900-25-043333 | 4 | 9 | IS | 0 | H | Facilities Expense | 0001213900-25-043333 | Facilities | 0 |
| 0001213900-25-043333 | 4 | 10 | IS | 0 | H | Costs And Expenses | us-gaap/2025 | Total costs and expenses | 0 |
| 0001213900-25-043333 | 4 | 11 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Operating loss | 0 |
| 0001213900-25-043333 | 4 | 13 | IS | 0 | H | Other Nonoperating Income | us-gaap/2025 | Other income | 0 |
| 0001213900-25-043333 | 4 | 14 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2025 | Interest expense, net | 1 |
| 0001213900-25-043333 | 4 | 15 | IS | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2025 | Foreign exchange loss | 0 |
| 0001213900-25-043333 | 4 | 16 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Loss before provision for income taxes | 0 |
| 0001213900-25-043333 | 4 | 17 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Income tax expense | 1 |
| 0001213900-25-043333 | 4 | 18 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-043333 | 4 | 19 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net loss per share, basic (in Dollars per share) | 0 |
| 0001213900-25-043333 | 4 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Net loss per share, fully diluted (in Dollars per share) | 0 |
| 0001213900-25-043333 | 4 | 21 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted average shares of common stock outstanding, basic (in Shares) | 0 |
| 0001213900-25-043333 | 4 | 22 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Weighted average number of shares of common stock, diluted (in Shares) | 0 |
| 0001213900-25-043333 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-043333 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-043333 | 5 | 10 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Share-based compensation | 0 |
| 0001213900-25-043333 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Gross | us-gaap/2025 | Issuance of common stock upon vesting of restricted stock units | 0 |
| 0001213900-25-043333 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | Issuance of common stock upon vesting of restricted stock units (in Shares) | 0 |
| 0001213900-25-043333 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Issuance of privately placed shares, net | 0 |
| 0001213900-25-043333 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Issuance of privately placed shares, net (in Shares) | 0 |
| 0001213900-25-043333 | 5 | 15 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-043333 | 5 | 16 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-043333 | 5 | 17 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-043333 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-043333 | 6 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
| 0001213900-25-043333 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Share-based compensation | 0 |
| 0001213900-25-043333 | 6 | 6 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | Amortization of right-of-use asset | 0 |
| 0001213900-25-043333 | 6 | 7 | CF | 0 | H | Other Noncash Expense | us-gaap/2025 | Non-cash interest | 0 |
| 0001213900-25-043333 | 6 | 8 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2025 | Amortization of debt premium and debt issuance costs | 0 |
| 0001213900-25-043333 | 6 | 10 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable and unbilled receivables | 1 |
| 0001213900-25-043333 | 6 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other assets | 1 |
| 0001213900-25-043333 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-043333 | 6 | 13 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-043333 | 6 | 14 | CF | 0 | H | Increase Decrease In Accrued Fiduciary Obligations | 0001213900-25-043333 | Accrued fiduciary obligations | 1 |
| 0001213900-25-043333 | 6 | 15 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Operating lease liabilities | 0 |
| 0001213900-25-043333 | 6 | 16 | CF | 0 | H | Increase Decrease In Other Operating Liabilities | us-gaap/2025 | Other liabilities | 0 |
| 0001213900-25-043333 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001213900-25-043333 | 6 | 19 | CF | 0 | H | Proceeds From Sale Of Business Unit | 0001213900-25-043333 | Proceeds from sale of business unit | 0 |
| 0001213900-25-043333 | 6 | 20 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash provided by investing activities | 0 |
| 0001213900-25-043333 | 6 | 22 | CF | 0 | H | Proceeds From Sale Of Future Cash Receipts On Accounts Receivable | 0001213900-25-043333 | Proceeds from sale of future cash receipts on accounts receivable | 0 |
| 0001213900-25-043333 | 6 | 23 | CF | 0 | H | Proceeds From Convertible Debt | us-gaap/2025 | Proceeds from issuance of debentures (Note 7) | 0 |
| 0001213900-25-043333 | 6 | 24 | CF | 0 | H | Payments Of Debt Issuance Costs | us-gaap/2025 | Payments of debt issuance costs | 1 |
| 0001213900-25-043333 | 6 | 25 | CF | 0 | H | Payments To Buyer Of Receivables | 0001213900-25-043333 | Payments to buyer of receivables | 1 |
| 0001213900-25-043333 | 6 | 26 | CF | 0 | H | Repayments Of Convertible Debt | us-gaap/2025 | Payments on convertible debentures (Note 7) | 1 |
| 0001213900-25-043333 | 6 | 27 | CF | 0 | H | Payments To Seller For Acquisition | 0001213900-25-043333 | Payments to seller for acquisition | 1 |
| 0001213900-25-043333 | 6 | 28 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Proceeds from issuance of common stock in a private offering, net | 0 |
| 0001213900-25-043333 | 6 | 29 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001213900-25-043333 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Net increase in cash, cash equivalents and restricted cash | 0 |
| 0001213900-25-043333 | 6 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash, cash equivalents and restricted cash at beginning of period | 0 |
| 0001213900-25-043333 | 6 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash, cash equivalents and restricted cash at end of period | 0 |
| 0001213900-25-043333 | 6 | 34 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001213900-25-043333 | 6 | 35 | CF | 0 | H | Restricted Cash Current | us-gaap/2025 | Restricted cash | 0 |
| 0001213900-25-043333 | 6 | 36 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Total cash, cash equivalents and restricted cash shown in the condensed consolidated statement of cash flows | 0 |
| 0001213900-25-043333 | 6 | 38 | CF | 0 | H | Interest Paid Net | us-gaap/2025 | Cash paid for interest | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |